1. FDA actions.
- Subjects
ANTIANDROGENS ,ANTICOAGULANTS ,ANTINEOPLASTIC agents ,FRAUD prevention ,BUTYRIC acid ,CROTON oil ,PYRIDINE ,STROKE prevention ,COLON tumors ,DRUGSTORES ,MULTIPLE sclerosis ,PROSTATE tumors ,RECTUM tumors ,ELECTRONIC commerce ,DRUG approval ,THERAPEUTICS - Abstract
The article provides updates on the latest activities of the FDA. The FDA has approved teriflunomide, a once-daily oral medication for the treatment of relapsing forms of multiple sclerosis (MS). The FDA review of Pfizer and Bristol-Myers Squibb's novel oral anticoagulant (NOAC) apixaban (Ehquis) has been inexplicably delayed to March 17, 2013. A nationwide campaign has been launched by the FDA to raise awareness about online pharmacies, called BeSafeRx - Know Your Online Pharmacy.
- Published
- 2012